Marksans Pharma Ltd. — Earnings Release 2019

Nov 13, 2018

·4· Marksans Pharma Ltd.

SSE Limited Corporate Relation Department Phiroze Jeejeeboi Towers, Dalal Street, Mumbai - 400001. Scrip Code: 524404

National Stock Exchange of India Limited Listing Department Exchange Plaza, C-l, Block-G, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051. Symbol: MARKSANS

Yours faithfully, For Marksans Pharma Limited J?oJJ~

Harshavardhan Panigrahi Company Secretary & Manager - Legal

Marksans Pharma Ltd.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • E-mail: info@marksanspharma.com www.marksanspharma.com

Marksans Pharma Ltd.

NEWS RELEASE 13[th] November 2018, Mumbai - India

• EBITDA was Rs 75.04 crores for the period, as compared to Rs.53.63 crores last year same period, registering growth of 39.92% over last year.

• Profit Before Tax was Rs.58.08 crores for the period, as compared to Rs.34.23 crores during last year same period, registering growth of 69.68% over last year.

• Profit after Tax was Rs.43.46 crores for the period, as compared to Rs.23.06 crores last year same period, registering growth of 88.46% over last year.

evenue I!!UreS - on so I a e

==> picture [440 x 143] intentionally omitted <==

----- Start of picture text ----- INR in croresHI FY 2018-19HIFY HIFY Growth % Mix %2018- 2017-2019 2018Europe, UK - Formulations 242.10 237.40 1.98% 47.78%US & North America -Formulations 191.19 189.58 0.85% 37.73%Australia & NZ - Formulations 58.24 51.53 13.02% 11.49%Rest ofWorld(ROW) 15.20 16.40 -7.29% 3.00%Consolidated Revenue from operations 506.73 494.91 2.39% 100.00%----- End of picture text -----

• Company achieved revenue of Rs. 242.1 0 crores from Europe, UK Formulation business as compared to Rs. 237.40 crores achieved during last year same period, registering growth of Rs.l.98%.

• US & North America Formulation business reported revenue ofRs. 191.19 crores, as against Rs.189.58 crores during last year same period registering growth of 0.85%.

• Australia & NZ Formulation business achieved revenue of Rs. 58.24 ~rores as compared to Rs.51.53 crores during last year same period registering growth of 13.02%.

• Rest of World Formulation business was Rs. 15.20 crores. Almost 97% of company's total revenue came from regulated markets of US, Europe, Australia & Canada.

  • ~. PH .marksanspharma.com

==> picture [227 x 72] intentionally omitted <==

----- Start of picture text ----- ·4·Marksans Pharma Ltd.----- End of picture text -----

Marksans Pharma Limited (www.marksanspharma.com) headquartered at Mumbai, India is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets. The company's manufacturing facilities are approved by several leading regulatory agencies. The company's robust product portfolio spreads over major therapeutic segments of CVS, CNS, Anti-diabetic, Pain Management, Gastroenterologicals and Antiallergies. The company is marketing these products globally.

Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, the progress and results of research and development, potential product characteristics and uses, product sales potential and target dates for product launch are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements. Marksans may, from time to time, make additional written and oral forwardlooking statements, including statements contained in the company's filings with the regulatory bodies and its reports to shareholders. The company assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.

Marksans Pharma Limited Il[th] Ploor, "GRANDEUR",Veera desai Extension Road, Oshiwara, Andheri - (West), Mumbai - 400053, India Tel:- +91 224001 2000, Pax:- +91 224001 2011.

www.marksanspharma.com

Marksans Pharma Ltd.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony. Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • Fax: +91-224001 2011 ! E-mail: info@marksanspharma.com